Wickley Peter J, Ding Xueqin, Murray Paul A, Damron Derek S
Kent State University, Kent, Ohio, USA.
Anesthesiology. 2006 May;104(5):970-7. doi: 10.1097/00000542-200605000-00013.
Myocardial protection by anesthetics is known to involve activation of protein kinase C (PKC). The authors' objective was to identify the PKC isoforms activated by propofol in rat ventricular myocytes. They also assessed the intracellular location of individual PKC isoforms before and after treatment with propofol.
Freshly isolated ventricular myocytes were obtained from adult rat hearts. Immunoblot analysis of cardiomyocyte subcellular fractions was used to assess translocation of individual PKC isoforms before and after exposure to propofol. An enzyme-linked immunosorbent assay kit was used for measuring PKC activity. Immunocytochemistry and confocal microscopy were used to visualize the intracellular location of the individual PKC isoforms.
Under baseline conditions, PKC-alpha, PKC-delta, and PKC-zeta were associated with both the cytosolic and membrane fractions, whereas PKC-epsilon was exclusively located in the cytosolic fraction. Propofol (10 microM) caused translocation of PKC-alpha, PKC-delta, PKC-epsilon, and PKC-zeta from cytosolic to membrane fraction and increased total PKC activity (211 +/- 17% of baseline; P = 0.003) in a dose-dependent manner. Immunocytochemical localization of the individual PKC isoforms demonstrated that propofol caused translocation of PKC-alpha to the intercalated discs and z-lines; PKC-delta to the perinuclear region; PKC-epsilon to sites associated with the z-lines, intercalated discs, and the sarcolemma; and PKC-zeta to the nucleus.
These results demonstrate that propofol causes an increase in PKC activity in rat ventricular myocytes. Propofol stimulates translocation of PKC-alpha, PKC-delta, PKC-epsilon, and PKC-zeta to distinct intracellular sites in cardiomyocytes. This may be a fundamentally important cellular mechanism of anesthesia-induced myocardial protection in the setting of ischemia-reperfusion injury.
已知麻醉药对心肌的保护作用涉及蛋白激酶C(PKC)的激活。作者的目的是确定丙泊酚在大鼠心室肌细胞中激活的PKC亚型。他们还评估了丙泊酚处理前后各PKC亚型在细胞内的定位。
从成年大鼠心脏获取新鲜分离的心室肌细胞。采用心肌细胞亚细胞组分的免疫印迹分析来评估丙泊酚处理前后各PKC亚型的转位情况。使用酶联免疫吸附测定试剂盒测量PKC活性。采用免疫细胞化学和共聚焦显微镜观察各PKC亚型在细胞内的定位。
在基线条件下,PKC-α、PKC-δ和PKC-ζ与胞质和膜组分均相关,而PKC-ε仅位于胞质组分中。丙泊酚(10μM)导致PKC-α、PKC-δ、PKC-ε和PKC-ζ从胞质转位至膜组分,并以剂量依赖方式增加总PKC活性(为基线的211±17%;P = 0.003)。各PKC亚型的免疫细胞化学定位显示,丙泊酚导致PKC-α转位至闰盘和Z线;PKC-δ转位至核周区域;PKC-ε转位至与Z线、闰盘和肌膜相关的部位;PKC-ζ转位至细胞核。
这些结果表明丙泊酚可使大鼠心室肌细胞中的PKC活性增加。丙泊酚刺激PKC-α、PKC-δ、PKC-ε和PKC-ζ转位至心肌细胞内不同的部位。这可能是缺血再灌注损伤情况下麻醉诱导心肌保护的一个根本重要的细胞机制。